Keryx Biopharma (KERX) Slumps Following Dilutive Stock Offering - InvestingChannel

Keryx Biopharma (KERX) Slumps Following Dilutive Stock Offering

ArticleRelated Press Releases (1) Related Articles (1) Stock Quotes (1) Comments (0)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

Top NewsMost Read Highlighted

Get AlertsKERX Hot Sheet

BUY ( Up)

Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) shares are dipping in after-hours trading Tuesday after announcing that it commenced a $55 million common stock offering.

Striking while the iron is hot, Keryx shares are up 143 percent since the close last Friday on stronger Zernex results.

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items – JOIN NOW